Loula Papageorgiou

Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases

Ève Zakine, Loula Papageorgiou, R. Bourguiba et al. · Journal of the American Academy of Dermatology · 2022 · 67 citations · Full text

Medicine, Dermatology, Pathology +10

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Grigoris Gerotziafas, Theodoros Ν. Sergentanis, Guillaume Voiriot et al. · Thrombosis and Haemostasis · 2020 · 47 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

Responses to facial and non-facial stimuli presented tachistoscopically in either or both visual fields by patients with the Capgras delusion and paranoid schizophrenics.

H. D. Ellis, Karel W. de Pauw, George N. Christodoulou et al. · Journal of Neurology Neurosurgery & Psychiatry · 1993 · 46 citations · Full text

Medicine, Psychiatry, Psychology +16

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Despina Fotiou, Theodoros Ν. Sergentanis, Loula Papageorgiou et al. · Blood Cancer Journal · 2018 · 34 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Theodoros P. Vassilakopoulos, Maria Dimopoulou, Maria K. Angelopoulou et al. · The Oncologist · 2016 · 26 citations · Full text

Medicine, Hematology, Oncology +12